-
1
Inter-reader agreement of RECIST and mRECIST criteria for assessing response to transarterial chemoembolization in hepatocellular carcinoma
Published 2025-05-01Subjects: “…RECIST…”
Get full text
Article -
2
The Desmoid Dilemma: Challenges and Opportunities in Assessing Tumor Burden and Therapeutic Response
Published 2025-05-01Subjects: Get full text
Article -
3
Feasibility of an artificial intelligence system for tumor response evaluation
Published 2024-10-01Subjects: “…RECIST 1.1…”
Get full text
Article -
4
Dedicated software to harmonize the follow-up of oncological patients
Published 2024-12-01Subjects: Get full text
Article -
5
Nivolumab monotherapy in metastatic colorectal cancer: current approaches to response evaluation
Published 2022-11-01Subjects: Get full text
Article -
6
-
7
The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma
Published 2025-04-01Subjects: “…RECIST…”
Get full text
Article -
8
RECIST 1.1 AND irRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE
Published 2019-09-01Subjects: Get full text
Article -
9
Interferons as Neoadjuvant Chemotherapy for Giant Cell Tumor: A Hospital-Based Prospective Pilot Study
Published 2024-08-01Subjects: Get full text
Article -
10
A perspective review on the systematic implementation of ctDNA in phase I clinical trial drug development
Published 2025-03-01Subjects: Get full text
Article -
11
Assessing immunotherapy response: going beyond RECIST by integrating early tumor growth kinetics
Published 2024-12-01Subjects: Get full text
Article